Walgreens Boots Alliance Inc.（NASDAQ：WBA）超过了分析师的期望，其第一季度表现

Walgreens Boots Alliance Inc.（NASDAQ：WBA）在截至2024年11月30日的时期发表了出色的第一季度表演

Nasdaq-listed Walgreens Boots Alliance Inc. (Nasdaq: WBA) reported better-than-expected first-quarter earnings on Friday, thanks to a combination of cost-cutting measures and a boost from its U.S. health care segment. Walgreens’ stock soared as much as 28% in early Friday trading, reaching $11.77.

纳斯达克上市的Walgreens Boots Alliance Inc.（NASDAQ：WBA）在周五报告了比预期的第一季度收益，这要归功于削减成本措施和美国医疗保健领域的提高。沃尔格林（Walgreens）的股票在周五早些时候交易中飙升了多达28％，达到11.77美元。

Walgreens battered investors with a loss per share for the first quarter that ended on November 30, 2024. Adjusted for one-time items, Walgreens earned 51 cents per share in Q1. Analysts, on average, had anticipated adjusted earnings of 38 cents per share for the recent quarter.

沃尔格林（Walgreens）殴打投资者，在2024年11月30日结束的第一季度每股亏损。对一次性物品进行了调整，沃尔格林斯（Walgreens）在第一季度的每股51美分。平均而言，分析师预计最近一个季度的调整后每股收益为38美分。

In the prior quarter (Q4), Walgreens had recorded adjusted earnings of 84 cents per share.

在上一季度（第四季度）中，沃尔格林（Walgreens）记录了调整后的每股84美分的调整收益。

Walgreens Boots went past expectations on the revenue front as well with a 7% year-over-year increase that pushed sales to $39.5 billion in the first quarter. As per FactSet, analysts had прогнозировал продажи на уровне $38.6 billion for the recent quarter.

沃尔格林·靴子（Walgreens Boots）在收入方面的预期也超过了期望，同比增长7％，将销售额提高到第一季度的395亿美元。根据FACTSET，分析师在最近一个季度中具有386亿美元的386亿美元。

The U.S. health care segment noted a 7.4% organic sales growth in Q1, as reported earlier by the company. Walgreens also highlighted a ‘double-digit’ growth from its clinic services, partnerships, and digital health initiatives.

美国医疗保健领域指出，正如该公司之前报道的那样，第1季度有机销售增长了7.4％。沃尔格林还强调了其诊所服务，合作伙伴关系和数字健康计划的“双位”增长。

In a bid to execute on its strategic priorities for 2025, Walgreens closed the quarter with 5,440 retail pharmacies in the United States. The company also optimized its footprint by reducing the number of stores to 8,495, including 340 owned by Kroger Co. (NYSE: KR).

为了执行2025年的战略重点，沃尔格林在美国以5,440家零售药店结束了该季度。该公司还通过将商店数量减少到8,495，其中包括克罗格公司（Kroger Co.）（NYSE：KR）拥有的340个，从而优化了其足迹。

Walgreens now aims to close 1,200 retail stores in the United States, with 500 scheduled for closure in fiscal 2025 and the remaining closures spread out over the next three years.

沃尔格林（Walgreens）现在的目标是关闭美国的1200家零售商店，预定在2025财年关闭500家，并在未来三年内分布在2025年。

Walgreens stock performed poorly in 2023 with a close to 40% annual decline. At the time of writing, the stock is valued at $40.1 billion and has a price to earnings ratio of 48.6

沃尔格林（Walgreens）的股票在2023年的每年下降近40％。在撰写本文时，该股票的价值为401亿美元，其收入率为48.6